Latest Breaking News On - Jounce therapeutics - Page 1 : comparemela.com

Next-Gen PARP Inhibitor Shows Benefit in Breast Cancer Patients

Next-Gen PARP Inhibitor Shows Benefit in Breast Cancer Patients
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongUnited kingdomHaihe biopharmaBiocity biopharmaCalithera biosciencesTerremoto biosciencesBridgene biosciencesEli lillyTimothya yapRadiopharm theranosticsArtios pharmaDaiichi sankyoInstitut gustave roussyAduro biotech incAtrin pharmaceuticals

Moderna : AACR INT Head & Neck Poster -April 08, 2024 at 04:52 pm EDT

CT141 mRNA-4157 Individualized Neoantigen Therapy +.

United kingdomNorth carolinaUnited statesSan diegoNew yorkDuke university medical centerCleveland clinicManishr patelJeffreym clarkeMartin gutierrezAcerta pharmaImmunitas incyteGenentech rocheDaiichi sankyoZhaojie zhangJustinf gainor

John Cox gets new biotech CEO gig, jumping to Dyne—Chutes & Ladders

John Cox gets new biotech CEO gig, jumping to Dyne—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United statesColin loveAnthony fauciDavid kersteinMax bayerMonica gostissaSushil patelAaron ondreyGeorge eliadesSyed rizviDaniel vlockPaul bullockMichael lenardoGabrielle massonJonathan schwartzMartin wilson

Amivantamab Offers Post-Progression Benefit in EGFRm NSCLC

Even if patients with EGFR-mutated lung cancer progress on amivantamab plus chemotherapy, there is a survival benefit over chemotherapy alone, follow-up analyses of PAPILLON and MARIPOSA-2 showed.

United statesUniversity of virginiaComunidad autonoma de catalunaMaria rosario garcia campeloRyand gentzlerEnriqueta felipMerck seronoAntonio passaroDaiichi sankyoZofia piotrowskaEli lillySociety for immunotherapy of cancerJazz pharmaceuticalsUniversity hospitala coruEuropean institute of oncologyJanssen pharmaceuticals

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesVincent brichardMonica gostissaNatural sciencesBaxter shireMartin luther university halle wittenbergPreclinical sciences at jounce therapeuticsV foundation scholar awardBoston children hospital harvard medical schoolInternational school for advanced studies in triesteLymphoma society special fellow awardChief scientific officerReno winterChief technicalAegle therapeuticsEgle therapeutic